Filter results
You can narrow down the results using the filters
Audience
Publication type
Topics
Our work
Diseases
9777 results
-
Improving communication, coordination and collaboration amongst alcohol and other drug treatment funders
This document looks at the improvements to the National Framework for Alcohol, Tobacco and other Drug Treatment. It looks at improving processes for communication, coordination, and collaboration (CCC) between and amongst alcohol and other drug (AOD) treatment funders. -
COVID-19 vaccination – vaccination data – 25 January 2023
This data file contains statistical data about Australia's COVID-19 vaccinations. -
COVID-19 vaccination – Geographic vaccination rates (LGA) – 25 January 2023
These reports list the percentage of people who have been vaccinated against COVID-19 by local government area (LGA). -
National Health and Medical Research Council – Projects funded
A list of National Health and Medical Research Council (NHMRC) projects and the committed funding. -
Life Saving Drugs Program – Fact sheet for pharmacists
This fact sheet gives answers to common questions about the role of pharmacies and authorised persons in managing Life Saving Drugs Program (LSDP) medicines. -
COVID-19 vaccine rollout update – 25 January 2023
This presentation, delivered on 25 January 2023, contains an update to Australia's COVID-19 vaccine rollout. -
Council of Elders communique – 8 and 9 December 2022
An update from the Council of Elders after their meeting on 8 and 9 December, 2022. -
National Aged Care Advisory Council communique – December 2022
The meeting of the National Aged Care Advisory Council was held on 15 December 2022. -
Life Saving Drugs Program – MPS I – Review summary and expert panel recommendations for consumers
This MPS I review considered laronidase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers. -
Life Saving Drugs Program – MPS I – Review summary and expert panel recommendations
This MPS I review considered laronidase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations. -
Life Saving Drugs Program – Fabry disease – Review summary and expert panel recommendations for consumers
This Fabry disease review considered the two enzyme replacement therapies (ERTs), agalsidase alfa and agalsidase beta. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumer -
Life Saving Drugs Program – Fabry disease – Review summary and expert panel recommendations
This Fabry disease review considered the two enzyme replacement therapies (ERTs), agalsidase alfa and agalsidase beta. The Expert Panel considered this review at its October 2020 meeting. These documents provide a summary of the review findings and recommendations. -
Private Health Insurance classification of MBS items 1 March 2023
This spreadsheet classifies MBS items by private health insurance clinical category and procedure type and includes MBS items commencing 1 March 2023. -
Commonwealth Home Support Programme (CHSP) Service Catalogue
This chart shows the types of services provided as part of the Commonwealth Home Support Programme (CHSP). -
COVID-19 vaccination – Geographic vaccination rates (LGA) – 20 January 2023
These reports list the percentage of people who have been vaccinated against COVID-19 by local government area (LGA). -
Coronavirus (COVID-19) common operating picture – 20 January 2023
This infographic issued on 20 January 2023 provides a weekly traffic light report of the coronavirus (COVID-19) situation across Australia. -
National Notifiable Diseases Surveillance System (NNDSS) fortnightly reports – 12 December 2022 to 8 January 2023
This report, and accompanying table, provide a fortnightly summary on notifications of Australia's nationally notifiable diseases for 12 December 2022 to 8 January 2023 -
COVID-19 vaccine rollout update – 20 January 2023
This presentation, delivered on 20 January 2023, contains an update to Australia's COVID-19 vaccine rollout. -
COVID-19 vaccination – vaccination data – 20 January 2023
This data file contains statistical data about Australia's COVID-19 vaccinations. -
COVID-19 outbreaks in Australian residential aged care facilities – 20 January 2023
This weekly report provides a snapshot of data on the impact of COVID-19 in residential aged care facilities nationally. The report includes data on the number of services impacted and number of staff and resident cases, as well as workforce, testing and PPE provided to affected services. -
Health Technology Assessment Policy and Methods Review – Reference committee meeting agenda – 27 January 2023
Health Technology Assessment Policy and Methods Review Reference Committee agenda for the 3rd meeting on 27 January 2023. -
Health Technology Assessment Policy and Methods Review – Reference committee communique – 1 December 2022 and 19 December 2022
A update from the Health Technology Assessment Policy and Methods review Reference Committee following their meeting on 1 December and 19 December 2022. -
Australian endemic tick-borne diseases
This document covers Australian tick-borne diseases -
Overseas-acquired tick-borne diseases: Lyme disease
This document provides evidence-based guidance for clinicians in community and hospital settings, as well as providing a reference source on DSCATT topics. This Guidance Note covers overseas-acquired Lyme disease. -
Introduction to ticks, Australian ticks and tick-borne diseases and illnesses
This document introduces the major concepts, issues and diseases and illnesses related to ticks, globally and in Australia.